LIFR and hepatocellular carcinoma: In order to characterize the receptor complexes used by rOSM on rat hepatoma cells, we performed RNA interference studies to abrogate the expression of the rat OSMR or blocked the rat LIFR by a LIFR-specific antagonist (LIF-05, [35]).